BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Bone cancer AND KLF4, EZF, 9314, ENSG00000136826, GKLF, O43474 AND Treatment
19 results:

  • 1. Vitamin D opposes multilineage cell differentiation induced by Notch inhibition and BMP4 pathway activation in human colon organoids.
    Bustamante-Madrid P; Barbáchano A; Albandea-Rodríguez D; Rodríguez-Cobos J; Rodríguez-Salas N; Prieto I; Burgos A; Martínez de Villarreal J; Real FX; González-Sancho JM; Larriba MJ; Lafarga M; Muñoz A; Fernández-Barral A
    Cell Death Dis; 2024 Apr; 15(4):301. PubMed ID: 38684650
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. FBXO22 Mediates the NGF/TRKA Signaling Pathway in bone Metastases in Prostate cancer.
    Zhang Y; Li W; Guo S; Wu Z; Zhang L; Liu Y; Li X; Guo X; Cao J; Yang C; Wang Z
    Am J Pathol; 2023 Sep; 193(9):1248-1266. PubMed ID: 37301536
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Paternity through use of assisted reproduction technology in male adult and childhood cancer survivors: a nationwide register study.
    Kitlinski M; Giwercman A; Elenkov A
    Hum Reprod; 2023 May; 38(5):973-981. PubMed ID: 36773319
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. LINC00629 protects osteosarcoma cell from ER stress-induced apoptosis and facilitates tumour progression by elevating klf4 stability.
    Wang Y; Zheng S; Han J; Li N; Ji R; Li X; Han C; Zhao W; Zhang L
    J Exp Clin Cancer Res; 2022 Dec; 41(1):354. PubMed ID: 36539799
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. klf4 Alleviates Hypertrophic Scar Fibrosis by Directly Activating BMP4 Transcription.
    Wang J; Zhao M; Zhang H; Yang F; Luo L; Shen K; Wang X; Li Y; Zhang J; Zhang J; Wang K; Li J; Wang Y; Yang Y; Hu D
    Int J Biol Sci; 2022; 18(8):3324-3336. PubMed ID: 35637963
    [No Abstract]    [Full Text] [Related]  

  • 6. Counterintuitive production of tumor-suppressive secretomes from Oct4- and c-Myc-overexpressing tumor cells and MSCs.
    Li K; Sun X; Zha R; Liu S; Feng Y; Sano T; Aryal UK; Sudo A; Li BY; Yokota H
    Theranostics; 2022; 12(7):3084-3103. PubMed ID: 35547745
    [No Abstract]    [Full Text] [Related]  

  • 7. CRISPR/Cas9-mediated overexpression of long non-coding RNA SRY-box transcription factor 21 antisense divergent transcript 1 regulates the proliferation of osteosarcoma by increasing the expression of mechanistic target of rapamycin kinase and Kruppel-like factor 4.
    Zhang W; Wang Q; Du H; Jiang S
    Bioengineered; 2022 Mar; 13(3):6678-6687. PubMed ID: 34696664
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Romidepsin hepatocellular carcinoma suppression in mice is associated with deregulated gene expression of bone morphogenetic protein and Notch signaling pathway components.
    Afaloniati H; Poutahidis T; Giakoustidis A; Gargavanis A; Giakoustidis D; Angelopoulou K
    Mol Biol Rep; 2021 Jan; 48(1):551-562. PubMed ID: 33393006
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. A narrative review of targeted therapy in meningioma, pituitary adenoma, and craniopharyngioma of the skull base.
    Martinez NL; Khanna O; Farrell CJ
    Chin Clin Oncol; 2020 Dec; 9(6):75. PubMed ID: 32819111
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. A multimodal treatment of carbon ions irradiation, miRNA-34 and mTOR inhibitor specifically control high-grade chondrosarcoma cancer stem cells.
    Vares G; Ahire V; Sunada S; Ho Kim E; Sai S; Chevalier F; Romeo PH; Yamamoto T; Nakajima T; Saintigny Y
    Radiother Oncol; 2020 Sep; 150():253-261. PubMed ID: 32717360
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. klf4
    von Spreckelsen N; Waldt N; Poetschke R; Kesseler C; Dohmen H; Jiao HK; Nemeth A; Schob S; Scherlach C; Sandalcioglu IE; Deckert M; Angenstein F; Krischek B; Stavrinou P; Timmer M; Remke M; Kirches E; Goldbrunner R; Chiocca EA; Huettelmaier S; Acker T; Mawrin C
    Acta Neuropathol Commun; 2020 Apr; 8(1):41. PubMed ID: 32245394
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Mechanisms underlying the promotion of osteosarcoma cell proliferation and invasion by lncRNA PBB12.
    Ma T; Liu A; Xu D; Zhang T
    Oncol Rep; 2020 Feb; 43(2):736-746. PubMed ID: 31894336
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Inhibition of klf4 by Statins Reverses Adriamycin-Induced Metastasis and cancer Stemness in Osteosarcoma Cells.
    Li Y; Xian M; Yang B; Ying M; He Q
    Stem Cell Reports; 2017 Jun; 8(6):1617-1629. PubMed ID: 28552603
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Frequent AKT1E17K mutations in skull base meningiomas are associated with mTOR and ERK1/2 activation and reduced time to tumor recurrence.
    Yesilöz Ü; Kirches E; Hartmann C; Scholz J; Kropf S; Sahm F; Nakamura M; Mawrin C
    Neuro Oncol; 2017 Aug; 19(8):1088-1096. PubMed ID: 28482067
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. FOXM1 in sarcoma: role in cell cycle, pluripotency genes and stem cell pathways.
    Kelleher FC; O'Sullivan H
    Oncotarget; 2016 Jul; 7(27):42792-42804. PubMed ID: 27074562
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Krüppel-like factor 4 promotes high-mobility group box 1-induced chemotherapy resistance in osteosarcoma cells.
    Huang J; Liu K; Song D; Ding M; Wang J; Jin Q; Ni J
    Cancer Sci; 2016 Mar; 107(3):242-9. PubMed ID: 26676883
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Valproic Acid Enhances iPSC Induction From Human bone Marrow-Derived Cells Through the Suppression of Reprogramming-Induced Senescence.
    Chen X; Zhai Y; Yu D; Cui J; Hu JF; Li W
    J Cell Physiol; 2016 Aug; 231(8):1719-27. PubMed ID: 26620855
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Inhibitory action of pristimerin on hypoxia‑mediated metastasis involves stem cell characteristics and EMT in PC-3 prostate cancer cells.
    Zuo J; Guo Y; Peng X; Tang Y; Zhang X; He P; Li S; Wa Q; Li J; Huang S; Xu D
    Oncol Rep; 2015 Mar; 33(3):1388-94. PubMed ID: 25571882
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Expression of androgen and estrogen signaling components and stem cell markers to predict cancer progression and cancer-specific survival in patients with metastatic prostate cancer.
    Fujimura T; Takahashi S; Urano T; Takayama K; Sugihara T; Obinata D; Yamada Y; Kumagai J; Kume H; Ouchi Y; Inoue S; Homma Y
    Clin Cancer Res; 2014 Sep; 20(17):4625-35. PubMed ID: 24987058
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.